What an AI agent reads on Enb Therapeutics
An assistant's crawler fetches the page once, without running JavaScript, and reads the text, the structured data and the links. Below is what it gets from enbpharma.com, taken from the copy the scanner kept.
2,388
characters of text without JavaScript
none
structured data for the business
2
of 3 AI crawlers turned away at the edge (GPTBot, ClaudeBot)
The words an agent gets
Title: ENB Therapeutics | · language en-US. First 1,800 of 2,388 characters:
ENB Therapeutics | Home About Pipeline News/Blog Contact Us Select Page ENB THERAPEUTICS: OVERCOMING IMMUNOTHERAPY RESISTANCE Two unique mechanisms that target the tumor microenvironment Learn More Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics’ ENB-003 for the Treatment of Ovarian Cancer Read More A New era in cancer therapy The vast majority of patients do not respond at all to cutting edge cancer immunotherapy. Many patients rapidly develop drug resistance to approved cancer therapies. ENB Therapeutics solves these problems with products to treat drug-resistant cancers. By targeting critical components in the microenvironment of the tumor, we empower the body’s immune system to do its job in effectively combating cancer. OVERCOMING IMMUNOTHERAPY RESISTANCE ACROSS MULTIPLE CANCER TYPES Two unique mechanisms ETBR: endothelin B receptor; TIL: tumor infiltrating lymphocytes; TLO: tertiary lymphoid organ; TME: tumor microenvironment ENLARGE GRAPHIC SWITCHING TUMORS FROM “COLD” TO “HOT” We are developing small molecules that turn off a common “switch” that activates critical pro-cancer components of the TME: the ETBR. The ETBR creates “cold” tumors by trapping immune cells in the circulation where they can’t kill tumors. Our therapies create “hot” tumors by restoring the ability of immune cells to infiltrate and kill tumors. Based on Chen & Mellman (2013) ENLARGE GRAPHIC CREATING NEW INTRATUMORAL TLOs Our therapies also promote robust intratumoral TLO formation. TLOs are functionally equivalent to lymph nodes and produce tumor-specific T- and B-cells. They act as “antibody factories to fight cancer” to induce long-lasting anti-cancer immunity and are associate
What it can say about the business
| A business type in JSON-LD | no |
| Name | no |
| Telephone | no |
| Address | no |
| Opening hours | no |
| Menu or price list | nothing |
| Cuisine in structured data | no |
| JSON-LD blocks | 0 |
The links it would act on
No booking or ordering link found. An agent has nothing to act on.
Everything here comes from fetching the homepage once as a crawler. The report turns it into a score and a list of fixes, with code to paste.